BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fine C, Roquin G, Terrebonne E, Lecomte T, Coriat R, Do Cao C, de Mestier L, Coffin E, Cadiot G, Nicolli P, Lepiliez V, Hautefeuille V, Ramos J, Girot P, Dominguez S, Céphise FV, Forestier J, Hervieu V, Pioche M, Walter T. Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE). United European Gastroenterol J 2019;7:1102-12. [PMID: 31662867 DOI: 10.1177/2050640619861883] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Fu ZY, Kmeid M, Aldyab M, Lagana SM, Lee H. Composite intestinal adenoma-microcarcinoid: An update and literature review. World J Gastrointest Endosc 2021; 13(12): 593-606 [DOI: 10.4253/wjge.v13.i12.593] [Reference Citation Analysis]
2 Carvão J, Dinis-Ribeiro M, Pimentel-Nunes P, Libânio D. Neuroendocrine Tumors of the Gastrointestinal Tract: A Focused Review and Practical Approach for Gastroenterologists. GE Port J Gastroenterol 2021;28:336-48. [PMID: 34604465 DOI: 10.1159/000512089] [Reference Citation Analysis]
3 Papaefthymiou A, Laskaratos FM, Koffas A, Manolakis A, Gkolfakis P, Coda S, Sodergren M, Suzuki N, Toumpanakis C. State of the Art in Endoscopic Therapy for the Management of Gastroenteropancreatic Neuroendocrine Tumors. Curr Treat Options Oncol 2022. [PMID: 35511346 DOI: 10.1007/s11864-022-00986-w] [Reference Citation Analysis]
4 Waked B, De Maeyer F, Carton S, Pieter-Jan C, Vandamme T, Verslype C, Demetter P, Borbath I, Van Eycken L, Hoorens A, Geboes K, Van Damme N, Ribeiro S. Quality of pathology reporting and adherence to guidelines in rectal neuroendocrine neoplasms: a Belgian national study. Acta Clin Belg 2021;:1-9. [PMID: 34607538 DOI: 10.1080/17843286.2021.1985806] [Reference Citation Analysis]
5 Stier MW, Chapman CG, Shamah S, Donboli K, Yassan L, Waxman I, Siddiqui UD. Endoscopic resection is more effective than biopsy or EUS to detect residual rectal neuroendocrine tumor. Endosc Int Open 2021;9:E4-8. [PMID: 33403229 DOI: 10.1055/a-1300-1017] [Reference Citation Analysis]
6 Cha B, Shin J, Ko WJ, Kwon KS, Kim H. Prognosis of incompletely resected small rectal neuroendocrine tumor using endoscope without additional treatment. BMC Gastroenterol 2022;22:293. [PMID: 35681149 DOI: 10.1186/s12876-022-02365-z] [Reference Citation Analysis]
7 Shi WK, Hou R, Li YH, Qiu XY, Liu YX, Wu B, Xiao Y, Zhou JL, Lin GL. Long-term outcomes of transanal endoscopic microsurgery for the treatment of rectal neuroendocrine tumors. BMC Surg 2022;22:43. [PMID: 35120483 DOI: 10.1186/s12893-022-01494-2] [Reference Citation Analysis]
8 Cope J, Srirajaskanthan R. Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation? Curr Oncol Rep 2022. [PMID: 35084662 DOI: 10.1007/s11912-021-01172-1] [Reference Citation Analysis]
9 O'Neill S, Haji A, Ryan S, Clement D, Sarras K, Hayee B, Mulholland N, Ramage JK, Srirajaskanthan R. Nodal metastases in small rectal neuroendocrine tumours. Colorectal Dis 2021. [PMID: 34731512 DOI: 10.1111/codi.15978] [Reference Citation Analysis]
10 Brand M, Reimer S, Reibetanz J, Flemming S, Kornmann M, Meining A. Endoscopic full thickness resection vs. transanal endoscopic microsurgery for local treatment of rectal neuroendocrine tumors - a retrospective analysis. Int J Colorectal Dis 2021;36:971-6. [PMID: 33215239 DOI: 10.1007/s00384-020-03800-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li Y, Pan F, Sun G, Wang ZK, Meng K, Peng LH, Lu ZS, Dou Y, Yan B, Liu QS. Risk Factors and Clinical Outcomes of 54 Cases of Rectal Neuroendocrine Tumors with Incomplete Resection: A Retrospective Single-Center Study. Ther Clin Risk Manag 2021;17:1153-61. [PMID: 34764651 DOI: 10.2147/TCRM.S332838] [Reference Citation Analysis]
12 de Mestier L, Cadiot G. Rectal neuroendocrine tumors: is it all on first sight? Endoscopy 2021;53:710-2. [PMID: 34167158 DOI: 10.1055/a-1309-1721] [Reference Citation Analysis]
13 Fermi F, Andreasi V, Muffatti F, Crippa S, Tamburrino D, Partelli S, Falconi M. How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery. Curr Oncol Rep. [DOI: 10.1007/s11912-022-01200-8] [Reference Citation Analysis]
14 Ricci AD, Pusceddu S, Panzuto F, Gelsomino F, Massironi S, De Angelis CG, Modica R, Ricco G, Torchio M, Rinzivillo M, Prinzi N, Rizzi F, Lamberti G, Campana D. Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study. J Clin Med 2022;11:713. [PMID: 35160165 DOI: 10.3390/jcm11030713] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Son J, Park IJ, Yang DH, Kim J, Kim KJ, Byeon JS, Hong SM, Kim YI, Kim JB, Lim SB, Yu CS, Kim JC. Oncological outcomes according to the treatment modality based on the size of rectal neuroendocrine tumors: a single-center retrospective study. Surg Endosc 2021. [PMID: 34009477 DOI: 10.1007/s00464-021-08527-6] [Reference Citation Analysis]
16 Veyre F, Lambin T, Fine C, Fenouil T, Rostain F, Walter T, Pioche M. Endoscopic characterization of rectal neuroendocrine tumors with virtual chromoendoscopy: differences between benign and malignant lesions. Endoscopy 2021;53:E215-6. [PMID: 32916731 DOI: 10.1055/a-1244-9526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]